151 related articles for article (PubMed ID: 6969281)
1. beta-Lactamase activity in human pus.
Bryant RE; Rashad AL; Mazza JA; Hammond D
J Infect Dis; 1980 Oct; 142(4):594-601. PubMed ID: 6969281
[TBL] [Abstract][Full Text] [Related]
2. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
[TBL] [Abstract][Full Text] [Related]
3. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
Brook I; Yokum P
Chemotherapy; 1983; 29(1):18-23. PubMed ID: 6339177
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
5. Purification and properties of beta-lactamase from Bacteroides fragilis.
Britz ML; Wilkinson RG
Antimicrob Agents Chemother; 1978 Mar; 13(3):373-82. PubMed ID: 45494
[TBL] [Abstract][Full Text] [Related]
6. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
[TBL] [Abstract][Full Text] [Related]
7. Characterization of beta-lactamases in clinical isolates of Bacteroides.
Eley A; Greenwood D
J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Eley A; Greenwood D
J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
[TBL] [Abstract][Full Text] [Related]
9. beta-Lactamase activity in slow-growing nonpigmented mycobacteria and their sensitivity to certain beta-lactam antibiotics.
Kasik JE; Monick M; Schwarz B
Tubercle; 1980 Dec; 61(4):213-9. PubMed ID: 6792754
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.
Sutter VL; Finegold SM
J Infect Dis; 1975 Apr; 131(4):417-22. PubMed ID: 804023
[TBL] [Abstract][Full Text] [Related]
12. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
Schassan HH; Bentfeld G
Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
Hedberg M; Edlund C; Lindqvist L; Rylander M; Nord CE
J Antimicrob Chemother; 1992 Feb; 29(2):105-13. PubMed ID: 1506324
[TBL] [Abstract][Full Text] [Related]
14. Presence of beta-lactamase-producing bacteria and beta-lactamase activity in abscesses.
Brook I
Am J Clin Pathol; 1986 Jul; 86(1):97-101. PubMed ID: 3487973
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
Blandino G; Milazzo I; Fazio D; Puglisi S; Pisano M; Speciale A; Pappalardo S
J Chemother; 2007 Oct; 19(5):495-9. PubMed ID: 18073147
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
Dornbusch K; Nord CE; Olsson-Liljeqvist B
Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Bacteroides species to modern antimicrobial preparations.
Závadová M; Tynková S; Adensámová J; Brezinová L
J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):51-9. PubMed ID: 6602163
[TBL] [Abstract][Full Text] [Related]
18. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
Nakano V; Padilla G; do Valle Marques M; Avila-Campos MJ
Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
[TBL] [Abstract][Full Text] [Related]
19. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
20. Effect of abscess milieu on bactericidal activity of LY146032 against staphylococci.
Bryant RE; Mazza JA; Gardner EM
Eur J Clin Microbiol; 1987 Apr; 6(2):186-8. PubMed ID: 3036500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
